Cochrane Clinical Answers
Cochrane Clinical Answers (CCAs) provide a readable, digestible, clinically focused entry point to rigorous research from Cochrane systematic reviews. They are designed to be actionable and to inform decision making at the point of care and have been added to relevant sections of the main Best Practice text.
- What are the effects of interventions to improve inhaler technique in children with asthma?
- In children with chronic asthma, what are the benefits and harms of adding long-acting beta2-agonists compared with adding anti-leukotrienes to inhaled corticosteroids?
- How do anti-leukotriene agents compare with inhaled corticosteroids in the management of recurrent and/or chronic asthma in children?
- How does ciclesonide compare with other inhaled corticosteroids in children and adolescents with chronic asthma?
- What adverse events are associated with formoterol when used for the regular treatment of chronic asthma?
- What are the benefits and harms of adding anti‐leukotriene agents to inhaled corticosteroids for adults and adolescents with persistent asthma?
- For children with asthma, can exhaled nitric oxide levels help to guide treatment?
- What are the benefits and harms of home telemonitoring and remote feedback between clinic visits in people with asthma?
- What are the effects of school‐based interventions for children and adolescents with asthma?
- Does asthma education for school staff benefit children with asthma?
- In people with mild to moderate asthma, how do flu vaccines affect asthma symptoms?
Use of this content is subject to our disclaimer